2170 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Disease, Chronic Obstructive
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
2 Terminated Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea Syndrome
Intervention: Device: Polysomnography
3 Unknown  Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
4 Terminated
Has Results
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
5 Completed
Has Results
Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Budesonide/formoterol (Symbicort Turbuhaler);   Drug: Formoterol (Oxis Turbuhaler)
6 Recruiting A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
7 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Formoterol (OT)
8 Completed
Has Results
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Glycopyrronium bromide;   Drug: Placebo to glycopyrronium bromide;   Drug: Tiotropium
9 Recruiting A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Conditions: Asthma,;   Pulmonary Disease, Chronic Obstructive
Intervention: Other: Medical tests
10 Completed
Has Results
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149;   Drug: NVA237;   Drug: tiotropium;   Drug: Salbutamol/albuterol
11 Recruiting Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Chronic Obstructive Lung Disease;   Chronic Obstructive Airway Disease;   Chronic Bronchitis;   Emphysema
Interventions: Behavioral: Mindfulness-based cognitive therapy;   Behavioral: Pulmonary rehabilitation
12 Completed
Has Results
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
13 Completed
Has Results
A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
Conditions: Asthma;   Coronary Artery Disease;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Regadenoson;   Drug: Placebo
14 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
15 Terminated Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Asthma
Interventions: Other: Pulmonary disease management;   Other: Usual care
16 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate combination;   Drug: Other maintenance Treatments (OMT)
17 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate;   Drug: Anticholinergics
18 Completed Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Subjects with COPD;   Other: Subjects without COPD
19 Completed
Has Results
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 100 µg;   Drug: Placebo;   Drug: NVA237 200 µg
20 Active, not recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years